Delivery Order SPE2DB22D2005-SPE2DB23FJPH3
Award Date 5/17/23
Potential Completion Date 5/18/23
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,541.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML medical products, with a completion date of December 14, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,805.52 firm-fixed-price delivery order contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp is not designated as a set-aside contractor for this award. Amerisourcebergen Drug Corp...
- This federal contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order worth $2,047.30 and has a Firm Fixed Price pricing type. The contract is for the delivery of IPOL VIAL 5ML pharmaceutical products and has an ultimate completion date of April 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order with a Firm Fixed Price of $1,744.16. The contract is for the supply of IPOL VIAL 5ML to the Defense Logistics Agency, a defense agency, with an ultimate completion date of May 29, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award is a delivery order worth $20,920.06 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of IPOL VIAL 5ML medical supplies with a performance period through September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.80 firm fixed price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,976.00 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through May 23, 2023 and was awarded on May 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $3,799.72 and a period of performance through May 30, 2025. This delivery order contract is on a firm-fixed-price basis, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is a delivery order with a firm fixed-price pricing type, valued at $54,405.01, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of 4566173175 IPOL VIAL 5ML medical products, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...